1. Antiviral activity of K22 against members of the order Nidovirales
- Author
-
Volker Thiel, Adriaan H. de Wilde, Julie C. F. Rappe, Margo A. Brinton, Nicolas Ruggli, Philip V'kovski, Hanspeter Stalder, Christin Müller, Eric J. Snijder, Han Di, and John Ziebuhr
- Subjects
0301 basic medicine ,Cancer Research ,Arterivirus ,viruses ,DMSO, dimethyl sulfoxide ,Virus Replication ,DMEM, Dulbecco’s modified Eagle’s medium ,PEDV, porcine epidemic diarrhea virus ,DNA, deoxyribonucleic acid ,Piperidines ,Chlorocebus aethiops ,Torovirus ,White bream virus ,Replication organelles ,biology ,Antiviral drug ,MERS-CoV, Middle East respiratory syndrome coronavirus ,mRNA, messenger RNA ,TCID, tissue culture infective dose ,3. Good health ,Double membrane vesicles ,UTR, untranslated region ,Infectious Diseases ,HCV, hepatitis C virus ,Benzamides ,FBS, foetal bovine serum ,Nidoviruses ,RNA, Viral ,RVN, reticulo-vesicular network ,SHFV, simian haemorrhagic fever virus ,EToV, equine torovirus ,Carps ,Simian hemorrhagic fever virus ,CAVV, Cavally virus ,Coronaviridae ,medicine.drug_class ,SARS-CoV, severe acute respiratory syndrome coronavirus ,K22 ,EAV, equine arteritis virus ,RTC, replication-transcription complex ,Antiviral Agents ,Article ,Cell Line ,ER, endoplasmic reticulum ,03 medical and health sciences ,NS5A, non-structural protein 5A ,ORF, open reading frame ,Equartevirus ,Virology ,medicine ,IBV, avian infectious bronchitis virus ,Animals ,Porcine respiratory and reproductive syndrome virus ,RNA, Double-Stranded ,Mesocricetus ,FCoV, feline coronavirus ,CM, convoluted membrane ,RNA ,ICTV, International Committee for the Taxonomy of Viruses ,Epithelial Cells ,biology.organism_classification ,Porcine reproductive and respiratory syndrome virus ,DMV, double membrane vesicles ,nsp6, non-structural protein 6 ,PRRSV, porcine reproductive and respiratory syndrome virus ,030104 developmental biology ,Viral replication ,Cell culture ,RNA, ribonucleic acid ,dsRNA, double-stranded RNA ,Torovirinae - Abstract
Highlights • The anti-coronaviral compound K22 has broad antiviral activity against diverse nidoviruses. • K22 treatment reduces double-stranded RNA following nidovirus infection. • K22 displays antiviral activity in nidovirus infection models of different species., Recently, a novel antiviral compound (K22) that inhibits replication of a broad range of animal and human coronaviruses was reported to interfere with viral RNA synthesis by impairing double-membrane vesicle (DMV) formation (Lundin et al., 2014). Here we assessed potential antiviral activities of K22 against a range of viruses representing two (sub)families of the order Nidovirales, the Arteriviridae (porcine reproductive and respiratory syndrome virus [PRRSV], equine arteritis virus [EAV] and simian hemorrhagic fever virus [SHFV]), and the Torovirinae (equine torovirus [EToV] and White Bream virus [WBV]). Possible effects of K22 on nidovirus replication were studied in suitable cell lines. K22 concentrations significantly decreasing infectious titres of the viruses included in this study ranged from 25 to 50 μM. Reduction of double-stranded RNA intermediates of viral replication in nidovirus-infected cells treated with K22 confirmed the anti-viral potential of K22. Collectively, the data show that K22 has antiviral activity against diverse lineages of nidoviruses, suggesting that the inhibitor targets a critical and conserved step during nidovirus replication.
- Published
- 2018